Company profile: Double Rainbow Biosciences
1.1 - Company Overview
Company description
- Provider of sustainable supply of active pharmaceutical ingredients; access to rare or endangered ingredients for consumer health products; bioengineering solutions for ag tech addressing global food insecurity; PRISM enzyme modification platform to improve specificity and efficacy of medicines via glycosylation; HARMONY molecular biosynthesis platform for sustainable recreation of bioactive compounds; and biosynthetic production of Gastrodin.
Products and services
- Gastrodin Production: Commercial-scale biosynthetic production of Gastrodin, a natural analgesic with therapeutic applications, produced at commercial scale via biosynthesis
- HARMONY: Molecular biosynthesis platform, synthetic biology-driven, for sustainable recreation of bioactive compounds through synthetic biology
- PRISM: Enzyme modification platform, glycosylation-based, used to improve the specificity and efficacy of medicines through glycosylation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Double Rainbow Biosciences
Metenova
HQ: Sweden
Website
- Description: Provider of magnetic mixers for the global pharmaceutical and biotech industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Metenova company profile →
Evitria
HQ: Switzerland
Website
- Description: Provider of global antibody expression services specialized in CHO-based transient production of recombinant antibodies, including chimeric, bispecific, Fc-optimized, fusion, afucosylated (GlymaxX) and Fc-silenced (STR) variants. Offers bispecific formats (Duobody, IgG-scFvs, Knobs-into-Holes) and transient expression of secreted proteins (scFvs, extracellular domains, cytokines, viral proteins).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evitria company profile →
Seahorse Bioscience
HQ: United States
Website
- Description: Provider of analytical instruments, biomanufacturing systems, and consumable labware for biological research and drug discovery, serving scientists at academic institutions, pharmaceutical and biotech organizations, and OEM manufacturers of assay kits and lab instrument suppliers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seahorse Bioscience company profile →
BlinkBio
HQ: United States
Website
- Description: Provider of specialized bioorthogonal chemistries for the delivery of next-generation medicines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BlinkBio company profile →
Indigo Biosciences
HQ: United States
Website
- Description: Provider of nuclear receptor-focused products and services addressing therapeutic drug targets, including cell-based luciferase reporter assay kits for GPCR and nuclear receptors, Live Cell Multiplex assays to quantify live cells alongside nuclear receptor assays, INDIGlo luciferase detection reagent, environmental testing bioassays, and an ortholog assay portfolio for cross-species receptor activity comparison aiding selection of animal models for drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Indigo Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Double Rainbow Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Double Rainbow Biosciences
2.2 - Growth funds investing in similar companies to Double Rainbow Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Double Rainbow Biosciences
4.2 - Public trading comparable groups for Double Rainbow Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →